mibefradil and tamoxifen
mibefradil has been researched along with tamoxifen in 12 studies
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Capuzzi, SJ; Fisher, EG; García-Sastre, A; He, S; Li, H; Martínez-Romero, C; Muratov, EN; Qiu, X; Shinn, P; Sun, W; Tawa, G; Tropsha, A; Xu, M; Zheng, W; Zhu, W | 1 |
| Droogmans, G; Eggermont, J; Nilius, B; Prenen, J; Voets, T | 1 |
| Brès, V; Duvoid, A; Hurbin, A; Hussy, N; Moos, FC; Orcel, H; Rabié, A | 1 |
| De Clercq, E; Droogmans, G; Koolwijk, P; Lelkes, PI; Liekens, S; Manolopoulos, VG; Nilius, B; Peters, E; Voets, T | 1 |
| Conner, TD; Dooley, SN; Ecay, TW; Ferslew, KE; Gonce, JL; Gong, W; Houser, M; Monen, SH; Wondergem, R | 1 |
Reviews
1 review(s) available for mibefradil and tamoxifen
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Other Studies
11 other study(ies) available for mibefradil and tamoxifen
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Drug Discovery; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Humans; Molecular Structure; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Virus Internalization | 2018 |
Activation of volume-regulated chloride currents by reduction of intracellular ionic strength in bovine endothelial cells.
Topics: Action Potentials; Animals; Benzimidazoles; Benzylidene Compounds; Calcium Channel Blockers; Cattle; Cell Line; Cell Membrane Permeability; Chloride Channels; Dose-Response Relationship, Drug; Electric Conductivity; Endothelium, Vascular; Estrogen Antagonists; Extracellular Space; Genistein; Hypertonic Solutions; Hypotonic Solutions; Ion Channel Gating; Membrane Potentials; Mibefradil; Nitriles; Osmolar Concentration; Tamoxifen; Tetrahydronaphthalenes; Tyrphostins | 1998 |
Pharmacological characterization of volume-sensitive, taurine permeable anion channels in rat supraoptic glial cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetophenones; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Chloride Channels; Colforsin; Diffusion; Dose-Response Relationship, Drug; Gene Expression; In Situ Hybridization; Ion Channels; Male; Mibefradil; Neuroglia; Niflumic Acid; Nitrobenzoates; ortho-Aminobenzoates; Osmotic Pressure; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Supraoptic Nucleus; Tamoxifen; Taurine | 2000 |
Inhibition of angiogenesis by blockers of volume-regulated anion channels.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Cattle; Cells, Cultured; Chick Embryo; Chorion; Clomiphene; Collagen; Drug Combinations; Endothelium, Vascular; Fibrin; Humans; In Vitro Techniques; Ion Channels; Laminin; Male; Mibefradil; Neovascularization, Physiologic; Nitrobenzoates; Proteoglycans; Rats; Rats, Wistar; Tamoxifen | 2000 |
Blocking swelling-activated chloride current inhibits mouse liver cell proliferation.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Carcinogens; Cell Division; Cell Line; Chloride Channels; Chlorides; Hepatocytes; Hypertonic Solutions; Liver; Membrane Potentials; Mibefradil; Mice; Nitrobenzoates; Patch-Clamp Techniques; Sucrose; Tamoxifen; Water-Electrolyte Balance | 2001 |